Cargando…
A model for predicting degree of malignancy in patients with intraductal papillary mucinous neoplasm
BACKGROUND/OBJECTIVES: There is no predictive model available to address early stage malignant intraductal papillary mucinous neoplasm (IPMN) including high grade dysplasia (HGD) and pT1a (invasive component≤0.5 cm). The aim of this study was to establish an objective and sufficient model to predict...
Autores principales: | He, Xiangyi, Fan, Rong, Sun, Jing, Ren, Yanhao, Zhao, Xuesong, Rui, Weiwei, Yuan, Yaozong, Zou, Duowu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902908/ https://www.ncbi.nlm.nih.gov/pubmed/36761937 http://dx.doi.org/10.3389/fonc.2023.1087852 |
Ejemplares similares
-
MRI-Based Pancreatic Atrophy Is Associated With Malignancy or Invasive Carcinoma in Intraductal Papillary Mucinous Neoplasm
por: Lin, Tingting, et al.
Publicado: (2022) -
Intraductal Papillary Mucinous Neoplasm of Pancreas
por: Machado, Norman Oneil, et al.
Publicado: (2015) -
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression
por: Gentiluomo, Manuel, et al.
Publicado: (2023) -
Mucin Hypersecreting Intraductal Papillary
Neoplasm of the Pancreas
por: Kim, Anthony W., et al.
Publicado: (1999) -
Intraductal Papillary Mucinous Neoplasm of the Pancreas: An Update
por: Xiao, Shu-Yuan
Publicado: (2012)